Association of NPM-ALK PCR results in bone marrow with clinical risk factors and immunophenotype of the ALCL
. | All patients . | BM PCR patients, (%) . | P . | |
---|---|---|---|---|
Negative . | Positive . | |||
All patients | 80 | 42 (53) | 38 (47) | |
Skin | .999 | |||
No | 66 | 35 (53) | 31 (47) | |
Yes | 14 | 7 (50) | 7 (50) | |
Mediastinum | .002 | |||
No | 41 | 29 (71) | 12 (29) | |
Yes | 39 | 13 (33) | 26 (67) | |
Visceral organs* | .01 | |||
No | 59 | 36 (61) | 23 (39) | |
Yes | 21 | 6 (29) | 15 (71) | |
CNS | .34 | |||
No | 76 | 41 (54) | 35 (46) | |
Yes | 4 | 1 (25) | 3 (75) | |
BM | .002 | |||
Neg | 72 | 42 (58) | 30 (42) | |
Pos | 8 | 0 | 8 (100) | |
Stage† | .001 | |||
I | 8 | 8 (100) | 0 (0) | |
II | 14 | 12 (86) | 2 (14) | |
III | 48 | 21 (44) | 27 (56) | |
IV | 10‡ | 1 (10) | 9‡ (90) | |
Histologic subtype | .005 | |||
Common | 39 | 28 (72) | 11 (18) | |
sc, lh, mixed, giant, nfc | 36 | 14 (39) | 22 (61) | |
na | 5 | 0 | 5 | |
CD3 | .26 | |||
Neg | 46 | 27 (59) | 19 (41) | |
Pos | 31 | 14 (45) | 17 (55) | |
na | 3 | 1 (33) | 2 (67) |
. | All patients . | BM PCR patients, (%) . | P . | |
---|---|---|---|---|
Negative . | Positive . | |||
All patients | 80 | 42 (53) | 38 (47) | |
Skin | .999 | |||
No | 66 | 35 (53) | 31 (47) | |
Yes | 14 | 7 (50) | 7 (50) | |
Mediastinum | .002 | |||
No | 41 | 29 (71) | 12 (29) | |
Yes | 39 | 13 (33) | 26 (67) | |
Visceral organs* | .01 | |||
No | 59 | 36 (61) | 23 (39) | |
Yes | 21 | 6 (29) | 15 (71) | |
CNS | .34 | |||
No | 76 | 41 (54) | 35 (46) | |
Yes | 4 | 1 (25) | 3 (75) | |
BM | .002 | |||
Neg | 72 | 42 (58) | 30 (42) | |
Pos | 8 | 0 | 8 (100) | |
Stage† | .001 | |||
I | 8 | 8 (100) | 0 (0) | |
II | 14 | 12 (86) | 2 (14) | |
III | 48 | 21 (44) | 27 (56) | |
IV | 10‡ | 1 (10) | 9‡ (90) | |
Histologic subtype | .005 | |||
Common | 39 | 28 (72) | 11 (18) | |
sc, lh, mixed, giant, nfc | 36 | 14 (39) | 22 (61) | |
na | 5 | 0 | 5 | |
CD3 | .26 | |||
Neg | 46 | 27 (59) | 19 (41) | |
Pos | 31 | 14 (45) | 17 (55) | |
na | 3 | 1 (33) | 2 (67) |